GaBI - Generics and Biosimilars Initiative

GaBI - Generics and Biosimilars Initiative GaBI's mission - Building trust in cost-effective treatments

GaBI Online is a one-stop portal for global news on the recent developments in the field of generics and biosimilars, a repository of worldwide guidelines and an archive of related scientific information. GaBI Journal (official Journal of the Generics and Biosimilars Initiative) is an independent and peer reviewed academic Journal - encompasses all aspects of generic and biosimilar medicines development and use, from fundamental research to clinical application and policies.

14/01/2026

Guidance for applicants: the ETF scientific advice that facilitates clinical trial authorisations (SA-CTA)

China-based Tuodao Medical launches with surgical robot tech
12/01/2026

China-based Tuodao Medical launches with surgical robot tech

Tuodao Medical this week announced its launch as a developer of cutting-edge robotic solutions for intelligent medical care.

EMA approves teduglutide generic
09/01/2026

EMA approves teduglutide generic

Ten new medicines recommended for approval; another four medicines recommended for extension of their therapeutic indications

EMA approves rivaroxaban generic Rivaroxaban Koanaa
29/12/2025

EMA approves rivaroxaban generic Rivaroxaban Koanaa

14 new medicines recommended for approval; another six medicines recommended for extension of their therapeutic indications

Mechanisms influencing generic drug substitution behaviour under the national centralized drug procurement policy
26/12/2025

Mechanisms influencing generic drug substitution behaviour under the national centralized drug procurement policy

This study highlights the importance of enhancing physicians' positive attitudes towards bid-winning generics, fostering a supportive normative environment, and mitigating excessive perceived behavioral control. These strategies may strengthen prescribing intentions, support effective and sustainabl...

19/12/2025

The MAHA Strategy

Questions and answers for biological medicinal products
17/12/2025

Questions and answers for biological medicinal products

Questions and answers for biological medicinal products HumanBiologicalsRegulatory and procedural guidanceResearch and developmentScientific guidelines

Belgium to fight cancer with radioligand therapy boom by 2027
15/12/2025

Belgium to fight cancer with radioligand therapy boom by 2027

Belgium will modernise infrastructure, streamline reimbursement and ensure timely patient access to next-gen radioactive isotope cancer treatments

ANVISA launches new digital form for international users
12/12/2025

ANVISA launches new digital form for international users

New tool facilitates access to the Agency's information.

Adres

Postbus 10001
Mol
BE-2400

Telefoon

+32-474989572

Website

http://gabi-journal.net/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer GaBI - Generics and Biosimilars Initiative nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Praktijk

Stuur een bericht naar GaBI - Generics and Biosimilars Initiative:

Snelkoppelingen

Delen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram